Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On BioScrip Inc (NASDAQ:BIOS), Inovio Pharmaceuticals Inc(NYSEMKT:INO).
BioScrip Inc (NASDAQ:BIOS) shares decreased 1.26% to $7.43 in the last trading session. The company announced today that the Company will release its 2013 third quarter financial results on Wednesday, November 6, 2013, after the market closes.
Additionally, Wites & Kapetan, P.A. on Oct. 24 announced their investigation of BioScrip, Inc. (“BioScrip” or the “Company”)(BIOS) and a possible class action lawsuit which may allege that the Company and certain of its officers and directors committed violations of the Securities Exchange Act of 1934. On September 23, 2013, BioScrip disclosed in a Securities and Exchange Commission (SEC) Form 8-K filing that the Company received a civil investigative demand issued by the United States Attorney's Office for the Southern District of New York and a subpoena from the New York State Attorney General's Medicaid Fraud Control Unit regarding the distribution of the Novartis Pharmaceuticals Corporation product Exjade® by the Company's legacy specialty pharmacy division.
Are investors worried about the recent updates with BIOS? Find out with a free trend analysis HERE
Inovio Pharmaceuticals Inc(NYSEMKT:INO) shares decreased 2.50% to $1.95 in yesterday’s session. The company on Oct. 21 announced that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients. Under a 2011 collaborative development agreement, Inovio's affiliate, VGX International Inc. (KSE:011000), is fully funding and conducting the study at multiple sites in Korea. Inovio is also planning to evaluate this hepatitis C (HCV) vaccine in additional clinical studies in the U.S. beginning in 2014.
Is INO going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)